Coronavirus disease 2019 and the placenta: A literature review

• Published in: Placenta (Eastbourne) 2022-08, Vol.126, p.209-223
• Main Authors: Gesaka, Samwel R., Obimbo, Moses M., Wanyoro, Anthony
• Format: Article
• Language: English
• Subjects: ACE2; COVID-19; Female; Humans; Placenta - metabolism; Placental infection; Placental pathology; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2; Single-cell analysis; Trophoblasts - pathology
• ISSN: 0143-4004; 1532-3102
• DOI: 10.1016/j.placenta.2022.07.007

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has been implicated in the clinical pathology of multiple organs and organ systems. Due to the novelty of the disease, there is a need to review emerging literature to understand the profile of SARS-CoV-2 in the placenta. This review sought to evaluate the literature on the mediators, mechanism of entry, pathogenesis, detection, and pathology of SARS-CoV-2 in the placenta. Systematic literature searches found 96 eligible studies. Our review revealed that SARS-CoV-2 canonical mediators, angiotensin-converting enzyme-2 (ACE2), and transmembrane serine protease-2 (TMPRSS2) are variably expressed in various placenta compartments, including the villous cytotrophoblasts, syncytiotrophoblasts (STBs), and extravillous trophoblasts (EVTs) throughout pregnancy. Placental SARS-CoV-2 and coronavirus-associated receptors and factors (SCARFs), including basigin (BSG/CD147), dipeptidyl peptidase-4 (DPP4/CD26), cathepsin B/L (CTL B/L), furin, interferon-induced transmembrane protein (IFITM1-3), and lymphocyte antigen 6E (LY6E) may increase or reduce the permissiveness of the placenta to SARS-CoV-2. EVTs express genes that code for proteins that may drive viral pathogenesis in the placenta. Viral RNA, proteins, and particles were detected primarily in the STBs by in situ hybridization, immunohistochemistry, electron microscopy, and polymerase chain reaction. Placental pathology in SARS-CoV-2-infected placentas included maternal and fetal vascular malperfusion and a generally nonspecific inflammatory-immune response. The localization of SARS-CoV-2 receptors, proteases, and genes involved in coding proteins that drive viral pathogenesis in the placenta predisposes the placenta to SARS-CoV-2 infection variably in all pregnancy trimesters, with antecedent placental pathology. There is a need for further studies to explicate the mechanism of entry and pathogenesis of SARS-CoV-2 in the placenta. •ACE2 and TMPRSS2 RNA and proteins are variably expressed in the placenta.•Other receptors and factors may be involved in SARS-CoV-2 placental infection.•EVTs express genes that encode proteins that drive viral pathogenesis in the placenta.•Viral RNA, proteins, and particles are detected in placental compartments.•Placental pathology in SARS-CoV-2-infected placentas is nonspecific.